BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10759549)

  • 21. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth suppression of human laryngeal squamous cell carcinoma by adenovirus-mediated tissue factor pathway inhibitor gene 2.
    Sun Y; Xie M; Liu M; Jin D; Li P
    Laryngoscope; 2006 Apr; 116(4):596-601. PubMed ID: 16585865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
    Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M
    Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.
    Klotzbücher M; Wasserfall A; Fuhrmann U
    Am J Pathol; 1999 Nov; 155(5):1535-42. PubMed ID: 10550310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
    Inoue K; Perrotte P; Wood CG; Slaton JW; Sweeney P; Dinney CP
    Clin Cancer Res; 2000 Nov; 6(11):4422-31. PubMed ID: 11106263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells.
    Berlingieri MT; Manfioletti G; Santoro M; Bandiera A; Visconti R; Giancotti V; Fusco A
    Mol Cell Biol; 1995 Mar; 15(3):1545-53. PubMed ID: 7862147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts.
    Fedele M; Berlingieri MT; Scala S; Chiariotti L; Viglietto G; Rippel V; Bullerdiek J; Santoro M; Fusco A
    Oncogene; 1998 Jul; 17(4):413-8. PubMed ID: 9696033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMGI-C gene expression is not required for in vivo thyroid cell transformation.
    Scala S; Portella G; Vitagliano D; Ledent C; Chiappetta G; Giancotti V; Dumont J; Fusco A
    Carcinogenesis; 2001 Feb; 22(2):251-6. PubMed ID: 11181445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis.
    Tkachenko A; Ashar HR; Meloni AM; Sandberg AA; Chada KK
    Cancer Res; 1997 Jun; 57(11):2276-80. PubMed ID: 9187132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
    Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth.
    Pan XT; Zhu QY; Li DC; Yang JC; Zhang ZX; Zhu XG; Zhao H
    Chin Med J (Engl); 2008 Oct; 121(20):2031-6. PubMed ID: 19080270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model.
    Turturro F; Heineke HL; Drevyanko TF; Link CJ; Seth P
    Gene Ther; 2000 Jun; 7(11):930-3. PubMed ID: 10849552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
    Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.
    Chiappetta G; Bandiera A; Berlingieri MT; Visconti R; Manfioletti G; Battista S; Martinez-Tello FJ; Santoro M; Giancotti V; Fusco A
    Oncogene; 1995 Apr; 10(7):1307-14. PubMed ID: 7731681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line.
    Kazmierczak B; Bol S; Wanschura S; Bartnitzke S; Bullerdiek J
    Genes Chromosomes Cancer; 1996 Nov; 17(3):191-3. PubMed ID: 8946199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.